{"id":"https://openalex.org/W2016752850","doi":"https://doi.org/10.1016/j.molbrainres.2004.06.003","title":"Neuroprotective effect of tacrolimus (FK506) on ischemic brain damage following permanent focal cerebral ischemia in the rat","display_name":"Neuroprotective effect of tacrolimus (FK506) on ischemic brain damage following permanent focal cerebral ischemia in the rat","publication_year":2004,"publication_date":"2004-07-22","ids":{"openalex":"https://openalex.org/W2016752850","doi":"https://doi.org/10.1016/j.molbrainres.2004.06.003","mag":"2016752850","pmid":"https://pubmed.ncbi.nlm.nih.gov/15337315"},"language":"en","primary_location":{"id":"doi:10.1016/j.molbrainres.2004.06.003","doi":"https://doi.org/10.1016/j.molbrainres.2004.06.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.molbrainres.2004.06.003","pdf_url":null,"source":{"id":"https://openalex.org/S158036907","display_name":"Molecular Brain Research","issn_l":"0169-328X","issn":["0169-328X","1872-6941"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Brain Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083884252","display_name":"Takahisa Noto","orcid":"https://orcid.org/0000-0002-4641-4511","observed_orcids":["https://orcid.org/0000-0002-4641-4511"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takahisa Noto","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075601784","display_name":"Masayuki Ishiye","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Masayuki Ishiye","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049933472","display_name":"Yasuhisa Furuich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasuhisa Furuich","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084407310","display_name":"Yuriko Keida","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuriko Keida","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018059342","display_name":"Kiyotaka Katsuta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kiyotaka Katsuta","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061419966","display_name":"Akira Moriguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akira Moriguchi","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100865618","display_name":"Nobuya Matsuoka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nobuya Matsuoka","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037429743","display_name":"Ichiro Aramori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ichiro Aramori","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Toshio Goto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshio Goto","raw_affiliation_strings":["Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa, Osaka, 532-8514, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040899796","display_name":"Takehiko Yanagihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109193","display_name":"Osaka Neurological Institute","ror":"https://ror.org/01rgbbv42","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210109193"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takehiko Yanagihara","raw_affiliation_strings":["Osaka Neurological Research Institute, 1-6-18-202, Minamiichioka, Minato, Osaka 552-0011, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Osaka Neurological Research Institute, 1-6-18-202, Minamiichioka, Minato, Osaka 552-0011, Japan","institution_ids":["https://openalex.org/I4210109193"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075601784"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1304,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.75401182,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"128","issue":"1","first_page":"30","last_page":"38"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13796","display_name":"Neurological Disorders and Treatments","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13796","display_name":"Neurological Disorders and Treatments","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.019999999552965164,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fk506","display_name":"FK506","score":0.9909999966621399},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cerebral-ischemia","display_name":"cerebral ischemia","score":0.8820000290870667},{"id":"https://openalex.org/keywords/focal-cerebral-ischemia","display_name":"focal cerebral ischemia","score":0.8510000109672546},{"id":"https://openalex.org/keywords/cytochrome-c-release","display_name":"cytochrome c release","score":0.8700000047683716},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7649999856948853},{"id":"https://openalex.org/keywords/dna-fragmentation","display_name":"DNA fragmentation","score":0.949999988079071},{"id":"https://openalex.org/keywords/tunel-assay","display_name":"TUNEL","score":0.6800000071525574},{"id":"https://openalex.org/keywords/middle-cerebral-artery-occlusion","display_name":"middle cerebral artery occlusion","score":0.8889999985694885},{"id":"https://openalex.org/keywords/ischemic-penumbra","display_name":"ischemic penumbra","score":0.9049999713897705},{"id":"https://openalex.org/keywords/necrosis","display_name":"necrosis","score":0.5149999856948853},{"id":"https://openalex.org/keywords/cortical-infarction","display_name":"cortical infarction","score":0.6610000133514404}],"concepts":[{"id":"https://openalex.org/C196795494","wikidata":"https://www.wikidata.org/wiki/Q1624817","display_name":"TUNEL assay","level":3,"score":0.8125876188278198},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.69767165184021},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.6292768120765686},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6047000885009766},{"id":"https://openalex.org/C154113507","wikidata":"https://www.wikidata.org/wiki/Q411149","display_name":"Terminal deoxynucleotidyl transferase","level":4,"score":0.5591903924942017},{"id":"https://openalex.org/C2780577055","wikidata":"https://www.wikidata.org/wiki/Q2069532","display_name":"Penumbra","level":3,"score":0.5462994575500488},{"id":"https://openalex.org/C2775841333","wikidata":"https://www.wikidata.org/wiki/Q498179","display_name":"Middle cerebral artery","level":3,"score":0.5303623676300049},{"id":"https://openalex.org/C2778820722","wikidata":"https://www.wikidata.org/wiki/Q4862390","display_name":"Brain ischemia","level":3,"score":0.44440019130706787},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.4167790412902832},{"id":"https://openalex.org/C43759708","wikidata":"https://www.wikidata.org/wiki/Q3749256","display_name":"DNA fragmentation","level":4,"score":0.41527673602104187},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3931802213191986},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3785385191440582},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3737642168998718},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.35576048493385315},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2878921627998352},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.2640637755393982},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26076287031173706},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10003501176834106},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.09166589379310608}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002544","descriptor_name":"Cerebral Infarction","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002544","descriptor_name":"Cerebral Infarction","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020244","descriptor_name":"Infarction, Middle Cerebral Artery","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020244","descriptor_name":"Infarction, Middle Cerebral Artery","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D020287","descriptor_name":"In Situ Nick-End Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045304","descriptor_name":"Cytochromes c","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053938","descriptor_name":"DNA Fragmentation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.molbrainres.2004.06.003","doi":"https://doi.org/10.1016/j.molbrainres.2004.06.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.molbrainres.2004.06.003","pdf_url":null,"source":{"id":"https://openalex.org/S158036907","display_name":"Molecular Brain Research","issn_l":"0169-328X","issn":["0169-328X","1872-6941"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Brain Research","raw_type":"journal-article"},{"id":"pmid:15337315","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15337315","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain research. Molecular brain research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1528505919","https://openalex.org/W1837631563","https://openalex.org/W1869407264","https://openalex.org/W1938199221","https://openalex.org/W1966343462","https://openalex.org/W1968072196","https://openalex.org/W1969612832","https://openalex.org/W1972101997","https://openalex.org/W1975896299","https://openalex.org/W1978559408","https://openalex.org/W1984754431","https://openalex.org/W1996568613","https://openalex.org/W2006791750","https://openalex.org/W2013319326","https://openalex.org/W2014486362","https://openalex.org/W2017813077","https://openalex.org/W2018365938","https://openalex.org/W2020462222","https://openalex.org/W2027294322","https://openalex.org/W2029479814","https://openalex.org/W2036885170","https://openalex.org/W2038055601","https://openalex.org/W2041356239","https://openalex.org/W2043100717","https://openalex.org/W2045835005","https://openalex.org/W2050013469","https://openalex.org/W2055758470","https://openalex.org/W2055931315","https://openalex.org/W2057638542","https://openalex.org/W2057713336","https://openalex.org/W2062796704","https://openalex.org/W2090061267","https://openalex.org/W2094058760","https://openalex.org/W2113999599","https://openalex.org/W2119683782","https://openalex.org/W2138116386","https://openalex.org/W2138302361","https://openalex.org/W2144918294","https://openalex.org/W2162943360","https://openalex.org/W2167335405","https://openalex.org/W2168601768","https://openalex.org/W2331839996","https://openalex.org/W2396203597","https://openalex.org/W6683675123"],"related_works":["https://openalex.org/W2022543507","https://openalex.org/W2009407047","https://openalex.org/W2412683319","https://openalex.org/W1997010369","https://openalex.org/W2041356239","https://openalex.org/W2004980565","https://openalex.org/W2050291088","https://openalex.org/W2076507975","https://openalex.org/W2379464402","https://openalex.org/W1968072196"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}